EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tracking Utilization of Neoadjuvant Endocrine Therapy (NET) and Neoadjuvant Chemotherapy (NCT) for Hormone Receptor-Positive Breast Cancer (HR + BC) in the U.S.A. Over Time – A TriNetX Database Study

Jubin K Lim, Anna E Gibson, Jian He, Alexis Antonucci, Harry D Bear

Clinical Breast Cancer · 2026-07 · 26 (7) · 39-45

DOI: 10.1016/j.clbc.2026.05.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026-07. Verfasst von Jubin K Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Methodist Healthcare System, San Antonio, TX. Electronic address: jubin.lim@mhshealth.com. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Breast Neoplasms, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyBreast NeoplasmsAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMiddle AgedReceptors, EstrogenReceptors, ProgesteroneDatabases, FactualUnited StatesErb-b2 Receptor Tyrosine KinasesAdultChemotherapy, AdjuvantAgedMastectomy, Segmental

Stichwörter der Autor:innen

Breast conserving surgery (BCS), HER-2 negative breast cancerNeoadjuvant chemotherapy (NCT)Neoadjuvant endocrine therapy (NET)TriNetX Database

Substanzen

Receptors, EstrogenAntineoplastic Agents, HormonalReceptors, ProgesteroneErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Surgery, Methodist Healthcare System, San Antonio, TX. Electronic address: jubin.lim@mhshealth.com.
  • Department of Surgery, Virginia Commonwealth University, Richmond, VA.
  • Biostatistics Shared Resource, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA.
  • Department of Internal Medicine, Medical University of South Carolina at Charleston, Charleston, SC.
  • Division of Surgical Oncology, Departments of Surgery and Microbiology & Immunology and the Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA.

Zitieren

APA

Lim, J. K., Gibson, A. E., He, J., Antonucci, A., & Bear, H. D. (2026). Tracking Utilization of Neoadjuvant Endocrine Therapy (NET) and Neoadjuvant Chemotherapy (NCT) for Hormone Receptor-Positive Breast Cancer (HR + BC) in the U.S.A. Over Time – A TriNetX Database Study. Clinical Breast Cancer, 26(7), 39-45. https://doi.org/10.1016/j.clbc.2026.05.008

Vancouver

Lim JK, Gibson AE, He J, Antonucci A, Bear HD. Tracking Utilization of Neoadjuvant Endocrine Therapy (NET) and Neoadjuvant Chemotherapy (NCT) for Hormone Receptor-Positive Breast Cancer (HR + BC) in the U.S.A. Over Time – A TriNetX Database Study. Clinical Breast Cancer. 2026;26(7):39-45. doi:10.1016/j.clbc.2026.05.008

BibTeX
@article{Lim2026,
  author = {Lim, Jubin K and Gibson, Anna E and He, Jian and Antonucci, Alexis and Bear, Harry D},
  title = {Tracking Utilization of Neoadjuvant Endocrine Therapy (NET) and Neoadjuvant Chemotherapy (NCT) for Hormone Receptor-Positive Breast Cancer (HR + BC) in the U.S.A. Over Time – A TriNetX Database Study},
  journal = {Clinical Breast Cancer},
  year = {2026},
  volume = {26},
  number = {7},
  pages = {39--45},
  doi = {10.1016/j.clbc.2026.05.008}
}
Kostenlos starten →